Show an ad over header. AMP

I am the second

FDA approves Biogen's Alzheimer's drug despite lack of evidence

The FDA has approved Biogen's Alzheimer's drug, aducanumab, which will be marketed as Aduhelm.

Why it matters: Aduhelm is the first federally approved Alzheimer's treatment in roughly 18 years, but there is no conclusive evidence the drug slows the decline of memory and brain function.

This story is breaking news. Please check back for updates.

Related Articles

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories